Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 196
interventional 105
Observational 78
Registry 13

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug|placebo 24
Other 24
Drug 22
Procedure 12
Behavioral 6
Device 4
Behavioral|Drug 2
Biological 2
Dietary Supplement 2
Drug|Radiation 2
Biological|Other 1
Device|Diagnostic Test 1
Device|Drug|Procedure 1
Drug|Other 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 30
Germany 8
Canada 7
China 6
France 4
Australia 3
Denmark 3
India 3
Spain 3
Switzerland 3
Turkey 3
United Kingdom 3
Belgium 2
Poland 2
United States|Argentina|Belgium|Canada|Chile|China|France|Germany|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Spain|United Kingdom 2
United States|Puerto Rico 2
Australia|Belgium|Canada|Czechia|Denmark|Germany|Greece|Ireland|Israel|Italy|Poland|Portugal|Spain|United Kingdom 1
Belarus 1
Belgium|France|Germany|Netherlands|Portugal|Spain 1
Canada|France|Ireland|Italy|Netherlands|Russian Federation 1
Egypt 1
France|Italy 1
France|United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Czechia|Denmark|Finland|Germany|Greece|India|Israel|Italy|Japan|Malaysia|Mexico|Netherlands|Norway|Poland|Portugal|Spain|Sweden|Switzerland|Thailand|United Kingdom 1
Japan 1
Malta 1
Mexico 1
NA 1
Netherlands 1
Portugal 1
Russian Federation 1
Singapore 1
Spain|Australia|Czechia|Denmark|Finland|France|Greece|Hungary|Norway|Poland|Portugal|Russian Federation 1
United States|Australia|Brazil|Canada|Colombia|Germany|Greece|Romania|Russian Federation|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Australia|Canada|United Kingdom 1
United States|Canada|France|Germany|Israel|Italy|Korea, Republic of|Netherlands|Sweden|Switzerland|United Kingdom 1
United States|Canada|Italy 1
United States|Germany 1

Sites per Study

Site_count Study_Count
1 70
2 6
3 4
4 4
5 3
10 1
11 1
14 1
17 1
20 1
22 1
23 1
32 2
36 1
37 1
66 1
93 1
94 1
97 1
119 1
153 1
160 1

Phase

Phase Study_Count
N/A 49
Phase 2 19
Phase 3 13
Phase 4 9
Phase 2/Phase 3 8
Phase 1 3
Phase 1/Phase 2 3
Early Phase 1 1

Number of Arms

Number_of_Arms Count_of_Studies
1 32
2 60
3 3
4 5
5 2
8 1
NA 2

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 10 10.0000 10.0 10.00000 8.00000 20.00 10.0000 15.00000
1st Qu. 10 27.0000 12.5 15.00000 19.00000 25.75 40.0000 50.00000
Median 10 45.0000 15.0 20.00000 40.00000 124.00 122.0000 60.00000
Mean 10 128.8776 14.0 23.33333 84.94737 173.50 179.6923 74.88889
3rd Qu. 10 104.0000 16.0 30.00000 146.00000 263.75 194.0000 78.00000
Max. 10 2000.0000 17.0 40.00000 270.00000 500.00 663.0000 240.00000

Trial Group Type

group_type Group_Count
Experimental 107
Active Comparator 39
Placebo Comparator 26
Other 14
No Intervention 10
Sham Comparator 3
NA 2

Intervention Model

intervention_model Study_Count
Parallel Assignment 55
Single Group Assignment 37
Crossover Assignment 13

Primary Purpose

primary_purpose Study_Count
Treatment 69
Diagnostic 14
Other 8
Supportive Care 8
Basic Science 3
Health Services Research 2
Prevention 1

Observational Studies

Studies by Country

Country Study_Count
United States 18
NA 9
United Kingdom 8
France 7
Germany 6
Netherlands 5
China 3
Singapore 3
Canada 2
Israel 2
Italy 2
Japan 2
Austria 1
Belgium 1
Brazil 1
Denmark 1
Egypt 1
Italy|Romania|United Kingdom 1
Korea, Republic of 1
Qatar 1
Switzerland 1
United States|Canada 1
United States|Iceland 1

Sites per Study

Site_count Study_Count
1 65
2 6
3 1
4 3
6 1
8 1
26 1

Enrollment Metrics

Measure Observational
Min 8.00
1st Qu 76.00
Median 189.00
Mean 19709.85
3rd Qu 500.00
Max 1375842.00

Observation Model

observational_model Study_Count
Cohort 43
Case-Only 15
NA 5
Case-Control 4
Case Control 4
Other 3
Family-Based 2
Defined Population, Natural History 1
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 53
Retrospective 12
Cross-Sectional 6
NA 4
Longitudinal 1
Longitudinal, Retrospective 1
Other 1

Registries

Studies by Country

Country Study_Count
United States 3
Austria 1
Austria|France|Germany|Italy|United Kingdom 1
China 1
France|Germany|Italy|Turkey|United Kingdom 1
Japan 1
Korea, Republic of 1
NA 1
Turkey 1
United Kingdom 1
United States|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 8
5 1
7 1
42 1
47 1
86 1

Enrollment Metrics

Measure Registries
Min 120.000
1st Qu 600.000
Median 1000.000
Mean 1491.308
3rd Qu 2000.000
Max 5000.000

Registry Model

observational_model Study_Count
Cohort 9
Case-Only 2
Case-Control 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 12
Cross-Sectional 1

Follow-up

target_duration Study_Count
10 Years 3
5 Years 3
3 Years 2
1 Year 1
15 Years 1
4 Weeks 1
4 Years 1
60 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03824834 Morphine to Maximize the Benefits of Exercise Training in COPD or ILD and Persistent Breathlessness https://ClinicalTrials.gov/show/NCT03824834 Recruiting McGill University 2020-06-30
NCT03822780 Hydroxychloroquin (HCQ) in chILD of Genetic Defect https://ClinicalTrials.gov/show/NCT03822780 Recruiting Children’s Hospital of Fudan University 2025-12-30
NCT03302702 Duration of Exercise Program in Interstitial Lung Diseases. https://ClinicalTrials.gov/show/NCT03302702 Completed Izmir Katip Celebi University 2016-01-31
NCT03261037 A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period https://ClinicalTrials.gov/show/NCT03261037 Completed Hoffmann-La Roche 2019-11-27
NCT03221257 Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate https://ClinicalTrials.gov/show/NCT03221257 Recruiting University of California, Los Angeles 2021-12-31
NCT03215927 Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT03215927 Recruiting University of Pittsburgh 2020-12-31
NCT03142191 A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT03142191 Recruiting Celgene 2021-06-30
NCT03099187 A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT03099187 Completed Hoffmann-La Roche 2018-11-21
NCT03084419 APRIL (AbatacePt in Rheumatoid Arthritis-ILD) https://ClinicalTrials.gov/show/NCT03084419 Recruiting Cambridge University Hospitals NHS Foundation Trust 2020-03-01
NCT03068091 Assessment of Lung Movement With Computed Tomography (CT) https://ClinicalTrials.gov/show/NCT03068091 Completed University of Missouri-Columbia 2018-09-30
NCT03018756 Nebulized Fentanyl in Patients With Mild to Moderate Interstitial Lung Disease and Chronic Dyspnea https://ClinicalTrials.gov/show/NCT03018756 Active, not recruiting Queen’s University 2018-06-25
NCT02999178 Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) https://ClinicalTrials.gov/show/NCT02999178 Completed Boehringer Ingelheim 2019-04-23
NCT02990286 Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases https://ClinicalTrials.gov/show/NCT02990286 Recruiting University Hospital, Tours 2020-06-30
NCT02958917 Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity Pneumonitis https://ClinicalTrials.gov/show/NCT02958917 Active, not recruiting National Jewish Health 2020-07-31
NCT02934750 Pursed Lip Breathing in Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT02934750 Completed Centre hospitalier de l’Université de Montréal (CHUM) 2017-01-30
NCT02896205 Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT02896205 Completed Postgraduate Institute of Medical Education and Research 2017-07-01
NCT02858180 Hepatitis C Virus(HCV) Heart and Lung Study https://ClinicalTrials.gov/show/NCT02858180 Completed Duke University 2019-04-11
NCT02808871 Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1) https://ClinicalTrials.gov/show/NCT02808871 Recruiting Brigham and Women’s Hospital 2021-11-30
NCT02763540 Pathological Comparisons of Surgical Open Lung Biopsies and Cryobiopsies in Non-IPF ILD https://ClinicalTrials.gov/show/NCT02763540 Completed University Hospital, Montpellier 2018-03-30
NCT02713347 Advancing Symptom Alleviation With Palliative Treatment https://ClinicalTrials.gov/show/NCT02713347 Recruiting VA Office of Research and Development 2020-12-31
NCT02711657 Fibrocytes in Rheumatoid Arthritis, Asthma and Interstitial Lung-disease. https://ClinicalTrials.gov/show/NCT02711657 Completed Odense University Hospital 2016-06-30
NCT02633293 An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE https://ClinicalTrials.gov/show/NCT02633293 Active, not recruiting United Therapeutics 2022-11-30
NCT02630316 Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE https://ClinicalTrials.gov/show/NCT02630316 Completed United Therapeutics 2019-12-26
NCT02622412 Evaluation of a Multi-professional Breathlessness Service for Patients With Breathlessness Due to Any Advanced Disease https://ClinicalTrials.gov/show/NCT02622412 Completed Ludwig-Maximilians - University of Munich 2019-02-01
NCT02622022 Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT02622022 Completed University of Aarhus 2019-02-06
NCT02594839 Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT02594839 Completed Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 2018-01-31
NCT02497144 Neuromuscular Electrical Stimulation in Patients With Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT02497144 Completed Gazi University 2018-06-30
NCT02464592 Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps. A Multicenter Study https://ClinicalTrials.gov/show/NCT02464592 Completed Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2017-08-31
NCT02426229 Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma https://ClinicalTrials.gov/show/NCT02426229 Completed Medical University of South Carolina 2018-06-30
NCT02377739 Non-invasive Ventilation in Patients With Interstitial Lung Disease - a Feasibility Study https://ClinicalTrials.gov/show/NCT02377739 Recruiting Schön Klinik Berchtesgadener Land 2019-10-31
NCT02370693 Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT02370693 Recruiting Northwestern University 2020-06-30
NCT02370550 Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren’s Syndrome https://ClinicalTrials.gov/show/NCT02370550 Recruiting Peking University People’s Hospital 2021-03-31
NCT02251964 Rituximab in Interstitial Pneumonitis https://ClinicalTrials.gov/show/NCT02251964 Completed St. Antonius Hospital 2017-10-31
NCT02246023 Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy https://ClinicalTrials.gov/show/NCT02246023 Completed University of Zurich 2015-12-31
NCT02201654 Stylet vs No Stylet During EBUS TBNA https://ClinicalTrials.gov/show/NCT02201654 Completed Johns Hopkins University 2015-09-30
NCT02150616 Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and Sleep https://ClinicalTrials.gov/show/NCT02150616 Active, not recruiting University of Zurich 2020-12-31
NCT02143687 Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance https://ClinicalTrials.gov/show/NCT02143687 Active, not recruiting University of Zurich 2020-12-31
NCT02125916 Evaluating the Effect of Oxygentherapy on Concentration at Chronic Lung Patients https://ClinicalTrials.gov/show/NCT02125916 Completed University of Aarhus 2014-08-31
NCT02096107 Novartis Everolimus Transition https://ClinicalTrials.gov/show/NCT02096107 Completed Medical University of South Carolina 2017-05-31
NCT02075762 Comparison of Transbronchial, Cryoprobe, and VATS Biopsy for the Diagnosis of Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT02075762 Completed Johns Hopkins University 2018-12-31
NCT02036970 Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT https://ClinicalTrials.gov/show/NCT02036970 Completed Reata Pharmaceuticals, Inc. 2018-01-19
NCT02019641 The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT02019641 Recruiting National Institutes of Health Clinical Center (CC) 2021-12-31
NCT01972685 Comparison of Transbronchial, Cryoprobe and VATS Biopsy For the Diagnosis of Interstitial Lung Disease (ILD) https://ClinicalTrials.gov/show/NCT01972685 Completed Duke University 2018-03-30
NCT01955824 A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy https://ClinicalTrials.gov/show/NCT01955824 Completed Postgraduate Institute of Medical Education and Research 2014-11-30
NCT01948518 Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease https://ClinicalTrials.gov/show/NCT01948518 Completed The Cleveland Clinic 2012-06-30
NCT01933334 Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS) https://ClinicalTrials.gov/show/NCT01933334 Completed Genentech, Inc. 2014-09-30
NCT01906931 Ambulatory Oxygen for ILD https://ClinicalTrials.gov/show/NCT01906931 Completed The Alfred 2014-02-28
NCT01898143 Cardiorespiratory Response During Whole Body Vibration Training in Patients With Chronic Lung Disease https://ClinicalTrials.gov/show/NCT01898143 Completed Schön Klinik Berchtesgadener Land 2015-05-31
NCT01894113 Prospective, Randomised Multicenter Study Comparing the Efficacy of Transbronchial Forceps Biopsy With Cryobiopsy to Diagnose Interstitial Lung Disease. https://ClinicalTrials.gov/show/NCT01894113 Completed University Hospital Tuebingen 2014-05-31
NCT01862926 Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD https://ClinicalTrials.gov/show/NCT01862926 Active, not recruiting Royal Brompton & Harefield NHS Foundation Trust 2020-08-31
NCT04281784 Project to Improve Communication About Serious Illness–Hospital Study: Pragmatic Trial (Trial 1) https://ClinicalTrials.gov/show/NCT04281784 Recruiting University of Washington 2021-09-01
NCT01817686 Study of Default Options in Advance Directives https://ClinicalTrials.gov/show/NCT01817686 Completed Corporal Michael J. Crescenz VA Medical Center 2015-06-30
NCT01789996 The Six Minute Walk Test: Influence of Instruction on Results https://ClinicalTrials.gov/show/NCT01789996 Completed Inova Health Care Services 2014-11-30
NCT01781793 Mechanisms of Exertional Dyspnea in Fibrotic Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT01781793 Completed University of British Columbia 2016-04-30
NCT01713413 Effects of an Oxymizer on Endurance Time in Patients With Chronic Lung Diseases https://ClinicalTrials.gov/show/NCT01713413 Completed Schön Klinik Berchtesgadener Land 2014-02-28
NCT01624753 Fibered Confocal Fluorescence Microscopy Imaging in Patients With Diffuse Parenchymal Lung Diseases https://ClinicalTrials.gov/show/NCT01624753 Completed Singapore General Hospital 2017-11-30
NCT01570764 Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT01570764 Completed Assistance Publique - Hôpitaux de Paris 2018-02-22
NCT01553981 A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma https://ClinicalTrials.gov/show/NCT01553981 Completed Sanjay Gandhi Postgraduate Institute of Medical Sciences 2014-04-30
NCT01462006 Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF) https://ClinicalTrials.gov/show/NCT01462006 Active, not recruiting University of Virginia 2018-11-30
NCT01442779 Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT01442779 Completed Texas Tech University Health Sciences Center 2007-05-31
NCT04428957 Telemonitoring of Treatment Effects in Connective Tissue Disease-associated Interstitial Lung Disease (TEL-CTD-ILD) https://ClinicalTrials.gov/show/NCT04428957 Recruiting Medical Universtity of Lodz 2022-04-30
NCT03596528 Interstitial Lung Disease (ILD). Diagnostic Yield of Surgical Lung Biopsy Versus Cryobiopsy in the Same Surgical Stage. https://ClinicalTrials.gov/show/NCT03596528 Recruiting Hospital Clinic of Barcelona 2018-12-31
NCT04382547 Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells https://ClinicalTrials.gov/show/NCT04382547 Enrolling by invitation Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 2021-06-30
NCT04326036 Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection https://ClinicalTrials.gov/show/NCT04326036 Enrolling by invitation Healeon Medical Inc 2021-11-01
NCT04299945 Effects of Drinking Beetroot Juice on Exercise Performance in Patients With Fibrotic Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT04299945 Recruiting University of British Columbia 2022-12-31
NCT04224233 A Home-based Physical Activity Programme for Patients With Advanced Interstitial Lung Diseases (iLiFE) https://ClinicalTrials.gov/show/NCT04224233 Recruiting Aveiro University 2023-02-01
NCT04159584 Pilot Study: The Effects of Medical Music on Anxiety in Patients With ILD https://ClinicalTrials.gov/show/NCT04159584 Completed Weill Medical College of Cornell University 2019-09-11
NCT04139356 The Effect of Spontaneous Respiration on Pulse-oximetry Measurements https://ClinicalTrials.gov/show/NCT04139356 Recruiting Universidad Autonoma de Nuevo Leon 2019-11-15
NCT04100226 Vitamin D Deficiency and Effect of Its Supplementation on Interstitial Lung Diseases(ILD). https://ClinicalTrials.gov/show/NCT04100226 Active, not recruiting Cairo University 2019-11-01
NCT04036721 Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis https://ClinicalTrials.gov/show/NCT04036721 Recruiting National Institute for Tuberculosis and Lung Diseases, Poland 2021-02-01
NCT03979703 Yoga in Patients With Fibrosing Interstitial Lung Diseases https://ClinicalTrials.gov/show/NCT03979703 Recruiting Heidelberg University 2019-12-31
NCT03927235 The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in Different Freezing Time in the Diffuse Parenchymal Lung Diseases https://ClinicalTrials.gov/show/NCT03927235 Recruiting Guangzhou Institute of Respiratory Disease 2020-05-15
NCT03857854 Efficacy and Safety of Pirfenidone in Patient With Dermatomyositis Interstitial Lung Disease (Dm-ILD) https://ClinicalTrials.gov/show/NCT03857854 Recruiting Beijing Continent Pharmaceutical Co, Ltd. 2021-02-28
NCT03856853 Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT03856853 Recruiting Beijing Continent Pharmaceutical Co, Ltd. 2021-02-10
NCT03814317 Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03814317 Recruiting University of Florida 2020-09-30
NCT03800914 High Intensity Interval Training in Fibrotic Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT03800914 Recruiting Monash University 2021-04-30
NCT03752892 Partitioned Training of Patients With Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT03752892 Recruiting West Park Healthcare Centre 2021-03-31
NCT03737409 PFOX: Pulmonary Fibrosis Ambulatory Oxygen Trial https://ClinicalTrials.gov/show/NCT03737409 Recruiting Monash University 2023-12-01
NCT03729583 The Effects of Breathing Retraining in Patients With Interstitial Lung Diseases https://ClinicalTrials.gov/show/NCT03729583 Completed University of Malta 2017-11-30
NCT03727568 Study Comparing Two Different Methods of Cryobiopsy in the Interstitial Lung Diseases https://ClinicalTrials.gov/show/NCT03727568 Recruiting University Hospital, Essen 2020-10-11
NCT03726398 CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH https://ClinicalTrials.gov/show/NCT03726398 Recruiting University of Arizona 2020-01-31
NCT03718780 Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise https://ClinicalTrials.gov/show/NCT03718780 Recruiting Centre Hospitalier Metropole Savoie 2020-08-31
NCT03675581 A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) https://ClinicalTrials.gov/show/NCT03675581 Completed Boehringer Ingelheim 2019-10-09
NCT03630211 Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis https://ClinicalTrials.gov/show/NCT03630211 Recruiting University of Pittsburgh 2023-08-01
NCT03561818 Comparison of PR Efficiency in Home-based With Hospital-based PR in Bronchiectasis https://ClinicalTrials.gov/show/NCT03561818 Recruiting Istanbul Medipol University Hospital 2020-12-30
NCT03560154 Effects of Whole Body Vibration Training in Patients With Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT03560154 Active, not recruiting Istanbul University 2019-09-30
NCT03516994 Reducing Disparities in the Quality of Advance Care Planning for Older Adults https://ClinicalTrials.gov/show/NCT03516994 Enrolling by invitation Duke University 2022-09-01
NCT03485378 Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT03485378 Recruiting Lawson Health Research Institute 2022-09-20
NCT01079143 Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients https://ClinicalTrials.gov/show/NCT01079143 Completed Novartis 2012-06-30
NCT01064609 "Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps. https://ClinicalTrials.gov/show/NCT01064609 Completed Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2012-09-30
NCT00883129 Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II) https://ClinicalTrials.gov/show/NCT00883129 Completed University of California, Los Angeles 2015-01-31
NCT00882817 Pulmonary Rehabilitation in Interstitial Lung Diseases https://ClinicalTrials.gov/show/NCT00882817 Completed KU Leuven 2011-10-31
NCT03929120 Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD) https://ClinicalTrials.gov/show/NCT03929120 Recruiting Mayo Clinic 2020-05-31
NCT04093024 A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD). https://ClinicalTrials.gov/show/NCT04093024 Recruiting Boehringer Ingelheim 2021-10-01
NCT03820726 A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) https://ClinicalTrials.gov/show/NCT03820726 Active, not recruiting Boehringer Ingelheim 2022-08-31
NCT03313180 A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis. https://ClinicalTrials.gov/show/NCT03313180 Active, not recruiting Boehringer Ingelheim 2022-12-31
NCT02796781 Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases https://ClinicalTrials.gov/show/NCT02796781 Recruiting Shanghai East Hospital 2021-04-30
NCT04138173 Enhancing Physical Activity in Patients With Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT04138173 Recruiting KU Leuven 2021-10-31
NCT00705133 Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00705133 Completed University of California, Los Angeles 2011-01-31
NCT00694850 Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH) https://ClinicalTrials.gov/show/NCT00694850 Active, not recruiting Bayer 2021-10-01
NCT00678821 Aerobic Exercise in Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00678821 Completed National Institutes of Health Clinical Center (CC) 2015-09-23
NCT00578565 Rituximab in Rheumatoid Arthritis Lung Disease https://ClinicalTrials.gov/show/NCT00578565 Completed Mayo Clinic 2011-06-30
NCT00504348 Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus https://ClinicalTrials.gov/show/NCT00504348 Completed Tokyo Medical and Dental University 2011-01-31
NCT00319033 Open-label Study With Bosentan in Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT00319033 Completed Actelion 2006-02-28
NCT00129701 Can we Reduce Hospital Attendance Without Compromising Care by the Use of Telephone Consultation https://ClinicalTrials.gov/show/NCT00129701 Completed Imperial College London 2005-10-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03400839 Best Clinical Endpoints That Likely Induce Worse Prognosis in Interstitial Lung Diseases https://ClinicalTrials.gov/show/NCT03400839 Recruiting Universidade Estadual de Londrina 2020-10-01
NCT03396120 The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT03396120 Completed Assiut University 2017-12-01
NCT03300583 Toward Self-management in ILD https://ClinicalTrials.gov/show/NCT03300583 Recruiting Kingston University 2020-10-30
NCT03295279 WTC Chest CT Imaging Archive https://ClinicalTrials.gov/show/NCT03295279 Active, not recruiting Icahn School of Medicine at Mount Sinai 2021-08-31
NCT03238989 Interstitial Lung Disease Registry Construction https://ClinicalTrials.gov/show/NCT03238989 Recruiting Seoul National University Hospital 2023-12-31
NCT03136120 Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT03136120 Completed GlaxoSmithKline 2018-11-13
NCT03044431 Autologous Stem Cell Treatment for Chronic Lung Disease Study https://ClinicalTrials.gov/show/NCT03044431 Completed Lung Institute 2017-06-01
NCT03043898 Mapping Sound Propagation Through the Human Lung for Better Diagnosis https://ClinicalTrials.gov/show/NCT03043898 Recruiting University of Cambridge 2020-04-23
NCT03040674 An Observational Outcomes Study for Autologous Cell Therapy Among Patients With COPD and Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT03040674 Active, not recruiting Lung Institute 2020-12-31
NCT02988388 Lung Tissue Research Consortium https://ClinicalTrials.gov/show/NCT02988388 Completed National Heart, Lung, and Blood Institute (NHLBI) 2019-01-28
NCT02879773 Computed Tomography Assessment of Regional Ventilation (CURVE) https://ClinicalTrials.gov/show/NCT02879773 Completed Heart of England NHS Trust 2018-06-01
NCT02858791 MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT02858791 Completed Northwell Health 2017-12-21
NCT02827734 Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD) https://ClinicalTrials.gov/show/NCT02827734 Recruiting Universitätsmedizin Mannheim 2020-12-31
NCT02826265 Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease https://ClinicalTrials.gov/show/NCT02826265 Recruiting Universitätsmedizin Mannheim 2020-12-31
NCT02799771 HYPID (Pulmonary Hypertension in Interstitial Lung Disease) EXTENSION https://ClinicalTrials.gov/show/NCT02799771 Active, not recruiting Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires 2018-02-28
NCT02689102 Confocal Laser Endomicroscopy and Optical Coherence Tomography for Diagnosing ILD. https://ClinicalTrials.gov/show/NCT02689102 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2017-04-22
NCT02636452 Cardiopulmonary Exercise Testing in Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT02636452 Completed Wissenschaftliches Institut Bethanien e.V 2017-09-30
NCT02596841 Lung Diffusing Capacity for Nitric Oxide as a Marker of Fibrotic Changes in Idiopathic Interstitial Pneumonias https://ClinicalTrials.gov/show/NCT02596841 Completed IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 2015-05-31
NCT03388580 Predictors for Bronchoalveolar Lavage (BAL) Recovery Rate Derived From Quantified Computed Tomography (qCT) https://ClinicalTrials.gov/show/NCT03388580 Completed Universitätsmedizin Mannheim 2017-09-30
NCT02501668 The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT02501668 Completed Keimyung University Dongsan Medical Center 2015-07-31
NCT02380326 Innovation in Endobronchial Sampling https://ClinicalTrials.gov/show/NCT02380326 Recruiting KU Leuven 2020-12-31
NCT02369575 Identification of Novel Markers of Human Lung Disease https://ClinicalTrials.gov/show/NCT02369575 Recruiting Ohio State University 2020-02-29
NCT02229994 Development of a New Tool for Dyspnea Measurement in Chronic Respiratory Diseases https://ClinicalTrials.gov/show/NCT02229994 Completed Assistance Publique - Hôpitaux de Paris 2014-03-27
NCT02197364 The Role of KL-6 in the Clinical Diagnosis of ILD https://ClinicalTrials.gov/show/NCT02197364 Completed Shanghai Pulmonary Hospital, Shanghai, China 2014-04-30
NCT02159651 A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia https://ClinicalTrials.gov/show/NCT02159651 Completed Astellas Pharma Inc 2019-12-23
NCT01978171 Prediction of Everolimus-induced Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT01978171 Completed Radboud University 2018-01-15
NCT03869515 Genetic Causes and Clinical Features of Childhood Interstitial Lung Diseases in China https://ClinicalTrials.gov/show/NCT03869515 Recruiting Children’s Hospital of Fudan University 2021-12-30
NCT01600378 Prospective Data Collection of Patients With Diffuse Parenchymal Lung Diseases https://ClinicalTrials.gov/show/NCT01600378 Recruiting Singapore General Hospital 2022-04-30
NCT01600352 Specific Autoantibody Testing in Patients With Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT01600352 Completed Singapore General Hospital 2017-04-30
NCT01443598 Pulmonary Hypertension in Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT01443598 Completed Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires 2011-12-31
NCT01374542 Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications https://ClinicalTrials.gov/show/NCT01374542 Recruiting Singapore General Hospital 2020-05-31
NCT01361139 Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD) https://ClinicalTrials.gov/show/NCT01361139 Completed Echosense Ltd. 2014-10-31
NCT04441502 Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic https://ClinicalTrials.gov/show/NCT04441502 Recruiting IRCCS Policlinico S. Donato 2020-09-30
NCT04435327 Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19) https://ClinicalTrials.gov/show/NCT04435327 Recruiting University of Milano Bicocca 2021-04-30
NCT04430491 To Evaluate the Use of Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT04430491 Completed Maastricht University 2017-01-01
NCT04416100 Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04416100 Recruiting Medical University Innsbruck 2022-04-28
NCT04413149 Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease. https://ClinicalTrials.gov/show/NCT04413149 Completed Peking Union Medical College Hospital 2019-04-01
NCT04354220 Capnography Monitoring in Ventilated Children https://ClinicalTrials.gov/show/NCT04354220 Recruiting University Children’s Hospital, Zurich 2023-12-31
NCT04325217 Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan https://ClinicalTrials.gov/show/NCT04325217 Recruiting Boehringer Ingelheim 2024-03-31
NCT04313946 Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays https://ClinicalTrials.gov/show/NCT04313946 Recruiting Grigore T. Popa University of Medicine and Pharmacy 2020-08-16
NCT04227535 Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2 https://ClinicalTrials.gov/show/NCT04227535 Recruiting Assistance Publique - Hôpitaux de Paris 2027-03-01
NCT04184180 Effects of Inpatient Pulmonary Rehabilitation on Frailty in Patients After Lung-Transplantation https://ClinicalTrials.gov/show/NCT04184180 Recruiting Schön Klinik Berchtesgadener Land 2020-03-31
NCT04159129 Effects of Pulmonary Rehabilitation on Walking Speed in Patients With COPD or ILD Patients https://ClinicalTrials.gov/show/NCT04159129 Recruiting Schön Klinik Berchtesgadener Land 2020-04-30
NCT04119115 Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases https://ClinicalTrials.gov/show/NCT04119115 Recruiting William Beaumont Hospitals 2021-02-28
NCT04061356 Assessment of Exhaled Breath Condensate Hydrogen Peroxide (EBC H2O2) as Measured Using a New Device (Inflammacheckâ„¢) in Patients With Interstitial Lung Disease, Lung Cancer and Healthy Volunteers. https://ClinicalTrials.gov/show/NCT04061356 Recruiting Portsmouth Hospitals NHS Trust 2019-10-31
NCT04016168 Idiopathic Pulmonary Fibrosis and Serum Bank https://ClinicalTrials.gov/show/NCT04016168 Recruiting Rennes University Hospital 2019-10-22
NCT03977415 Interstitial Lung Disease in Early Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03977415 Recruiting National Jewish Health 2020-02-01
NCT03950583 The Clinical Course of Interstitial Pneumonia With Autoimmune Features https://ClinicalTrials.gov/show/NCT03950583 Recruiting Lawson Health Research Institute 2024-06-11
NCT03901196 Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy) https://ClinicalTrials.gov/show/NCT03901196 Recruiting University Hospital, Grenoble 2022-05-15
NCT03836417 Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective Study https://ClinicalTrials.gov/show/NCT03836417 Recruiting Lawson Health Research Institute 2022-02-28
NCT03704233 The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in Diffuse Parenchymal Lung Diseases https://ClinicalTrials.gov/show/NCT03704233 Recruiting Guangzhou Institute of Respiratory Disease 2020-10-20
NCT03641742 Families-At-risk for Interstitial Lung Disease Study https://ClinicalTrials.gov/show/NCT03641742 Recruiting Columbia University 2035-10-01
NCT03599414 CASPA: CArdiac Sarcoidosis in PApworth https://ClinicalTrials.gov/show/NCT03599414 Recruiting Papworth Hospital NHS Foundation Trust 2020-03-24
NCT03478826 Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD) https://ClinicalTrials.gov/show/NCT03478826 Recruiting Mayo Clinic 2028-01-31
NCT03437486 Mechanisms of Familial Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT03437486 Recruiting Vanderbilt University Medical Center 2021-04-30
NCT03416075 Mechanical Ventilation in Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT03416075 Completed Beijing Chao Yang Hospital 2017-12-31
NCT01110694 Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study https://ClinicalTrials.gov/show/NCT01110694 Completed Royal Brompton & Harefield NHS Foundation Trust 2018-09-30
NCT01088217 Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF) https://ClinicalTrials.gov/show/NCT01088217 Recruiting National Jewish Health 2022-06-30
NCT01055730 The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT01055730 Completed University of California, San Francisco 2013-01-31
NCT00926523 Biomarkers in the Evaluation of Chronic Lung Disease https://ClinicalTrials.gov/show/NCT00926523 Completed Northwell Health 2011-03-31
NCT02479126 Interstitial Lung Diseases in the Veterans Administration https://ClinicalTrials.gov/show/NCT02479126 Active, not recruiting Durham VA Medical Center 2020-11-30
NCT01714518 Cryobiopsy vs. VATS in Diagnosis of Interstitial Lung Diseases https://ClinicalTrials.gov/show/NCT01714518 Completed Wissenschaftliches Institut Bethanien e.V 2017-06-30
NCT03336736 The Role of Physical Activity and Diet Within Pulmonary Sarcoidosis https://ClinicalTrials.gov/show/NCT03336736 Completed Kingston University 2018-06-15
NCT02549248 Nanoparticles Analysis in Lung and Bronchi During Various Pulmonary Interstitial Diseases and Relationships With Their Aetiology https://ClinicalTrials.gov/show/NCT02549248 Completed Centre Hospitalier Universitaire de Saint Etienne 2015-04-30
NCT00741572 Individual Sensitivity for Interstitial Lung Diseases https://ClinicalTrials.gov/show/NCT00741572 Completed Maastricht University Medical Center 2009-06-30
NCT00512967 The Occurence of Inflammation and Oxidative Stress in Lung Diseases https://ClinicalTrials.gov/show/NCT00512967 Completed Maastricht University Medical Center NA
NCT00511290 Measurement of Soluble Factors and Particulate Matter in Induced Sputum and EBC in Inflammatory Diseases of the Lung https://ClinicalTrials.gov/show/NCT00511290 Completed Tel-Aviv Sourasky Medical Center NA
NCT00504361 Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar) https://ClinicalTrials.gov/show/NCT00504361 Completed Weill Medical College of Cornell University 2012-05-31
NCT00470327 A Study of the Natural Progression of Interstitial Lung Disease (ILD) https://ClinicalTrials.gov/show/NCT00470327 Recruiting University of Chicago 2020-12-31
NCT00820729 Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT00820729 Completed University of Aarhus 2011-03-31
NCT00453713 Race, Ethnicity, and Diffuse Parenchymal Lung Disease https://ClinicalTrials.gov/show/NCT00453713 Completed Columbia University 2013-08-31
NCT00362739 Blood Collection From Individuals With Lung Disease for Genetic Studies https://ClinicalTrials.gov/show/NCT00362739 Completed Weill Medical College of Cornell University 2015-08-31
NCT00258583 Dorothy P. and Richard P. Simmons Center for ILD Research Registry https://ClinicalTrials.gov/show/NCT00258583 Recruiting University of Pittsburgh 2025-07-31
NCT00027235 Popcorn Lung: the Discovery of a New Disease https://ClinicalTrials.gov/show/NCT00027235 Completed National Center for Research Resources (NCRR) NA
NCT00005317 Idiopathic Pulmonary Fibrosis–Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases https://ClinicalTrials.gov/show/NCT00005317 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005295 Idiopathic Pulmonary Fibrosis: a Case-control Study https://ClinicalTrials.gov/show/NCT00005295 Completed University of New Mexico NA
NCT00005290 Epidemiology of Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT00005290 Completed University of New Mexico NA
NCT00016627 Linkage Study in Familial Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT00016627 Completed National Heart, Lung, and Blood Institute (NHLBI) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03297775 Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT03297775 Recruiting University of Colorado, Denver 2027-06-30
NCT03099525 Treatment Outcome and Prognostic Factors for Rheumatoid Arthritis (RA) Patients With Interstitial Lung Disease (ILD) https://ClinicalTrials.gov/show/NCT03099525 Recruiting Hanyang University 2021-03-31
NCT03041623 Japanese Idiopathic Interstitial Pneumonias Registry https://ClinicalTrials.gov/show/NCT03041623 Active, not recruiting North East Japan Study Group 2021-03-31
NCT02951416 Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank https://ClinicalTrials.gov/show/NCT02951416 Recruiting University of Giessen 2025-01-31
NCT02852928 European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank https://ClinicalTrials.gov/show/NCT02852928 Recruiting Ludwig-Maximilians - University of Munich 2024-12-31
NCT02758808 Pulmonary Fibrosis Foundation Patient Registry https://ClinicalTrials.gov/show/NCT02758808 Recruiting University of Michigan 2021-03-31
NCT01915511 Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry https://ClinicalTrials.gov/show/NCT01915511 Recruiting Duke University 2025-01-31
NCT04370158 Interstitial Lung Diseases Cohort Study in China https://ClinicalTrials.gov/show/NCT04370158 Recruiting China-Japan Friendship Hospital 2020-12-31
NCT04095351 Connective Tissue Diseases and Lung Manifestations https://ClinicalTrials.gov/show/NCT04095351 Recruiting Medical University Innsbruck 2021-03-01
NCT04016181 The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study https://ClinicalTrials.gov/show/NCT04016181 Enrolling by invitation University of Edinburgh 2022-03-31
NCT03995654 Research of Burden of Interstititial Lung Diseases in Turkey https://ClinicalTrials.gov/show/NCT03995654 Active, not recruiting Karadeniz Technical University 2020-07-01
NCT03747627 BPF Genetics of ILD Study https://ClinicalTrials.gov/show/NCT03747627 Recruiting NHS Forth Valley 2024-01-22
NCT00014859 Epidemiology of Surfactant Protein-B Deficiency https://ClinicalTrials.gov/show/NCT00014859 Recruiting Washington University School of Medicine 2020-12-31